Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acquired immunodeficiency syndrome
acute disseminated encephalomyelitis
advances in neurology
adverse drug reaction
alemtuzumab
algorithm
amyloid angiopathy, cerebral
angiitis, granulomatous of CNS
angiitis, isolated of CNS
anti DNA agent
anti JC virus antibodies
antibiotics
antiviral agents
asymptomatic
ataxia
atypical
B 12 deficiency
bacterial infection
Behcet's syndrome
biologic markers
brain biopsy
brain biopsy, false negative
brain biopsy, negative
brainstem, lesion of
brentuximab
brucellosis, nervous system involvement with
Brudzinski's sign
carbon monoxide poisoning
carcinoma
CAT scan, abnormal
CAT scan, emission, abnormal
CD4 counts
central nervous system, infection of
central pontine myelinolysis
cerebellar atrophy, secondary
cerebellar degeneration
cerebellar lesion
cerebellum, disease of
cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy
cerebral venous thrombosis
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, gammaglobulin of
cerebrovascular accident, secondary prevention
chemotherapy, CNS treatment and complications with
cladribine
Clinical Pathologic Conference(C.P.C.)
coinfection
Collier's sign
complications
controversies in neurology
cortical blindness
cranial neuropathy
cytosine arabinoside
daclizumab
delay in diagnosis
demyelinating disease
dermatomyositis
disability, neurological
drug abuse
drug holiday
drug induced neurologic disorders
drug withdrawal
dysarthria
efalizumab
efficacy
electroencephalogram, abnormalities of
electron microscopy
encephalitis
encephalitis, brainstem
encephalitis, human immunodeficiency virus type 1
encephalitis, paraneoplastic
encephalitis, viral
epidemiology of neurology
Epstein-Barr virus
etanercept
evidence-based research
false negative
fever
fingolimod
gadolinium
gammaglobulin therapy, intravenous
gaze palsy, vertical
gliomatosis cerebri
Guillain Barre syndrome
hearing loss
hemiparesis
hemiplegia, progressive
hepatosplenomegaly
highly active antiretroviral therapy
Hodgkin's disease
human immunodeficiency virus type 1
hydrocephalus
hypercalcemia
hypertensive encephalopathy
iatrogenic neurologic disorders
immune checkpoint inhibitors
immune reconstitution inflammatory syndrome
immune-related adverse events
immunocompetent
immunofluorescent exam of CSF cells
immunomodulation
immunosuppression
immunosuppressive agents
immunotherapy
in situ hybridization
inclusion bodies
infection
infliximab
interferon
interferon beta 1-a
iododeoxyuridine
JC virus
JC virus cerebellar granule cell neuronopathy
JC virus encephalopathy
Kernig's sign
leukemia
leukemia, neurologic findings assoc.with
leukoencephalopathy
leukoencephalopathy, differential diagnosis
leukoencephalopathy, toxic
levamisole
level of consciousness, decreased
life expectancy
limbic encephalitis
listeriosis, CNS
lymph node biopsy
lymphadenopathy
lymphoma
lymphoma involving CNS
lymphoma, primary of CNS
meningismus
meningitis
midbrain
midbrain, lesion of
middle cerebellar peduncle
middle cerebellar peduncle, lesion
migraine
mitochondrial disease
monoclonal antibodies
mortality
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, diffusion weighted
MRI, magnetization transfer sequence
MRI, negative
MRI, ring sign
MRI, ring sign, open
MRI, serial
MRS
multiple sclerosis
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, relapsing
multiple sclerosis, treatment of
myoclonus
natalizumab
negative
neoplasm, primary of CNS
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic disease, multiple
neurologic signs
neurologic symptoms
neuromyelitis optica (Devic's disease)
neuropathology
neuropathy
neuropathy, iatrogenic
neuropathy, immune
neuropathy, medication induced
neuropathy, motor, multifocal
neuropathy, peripheral, treatment
nivolumab
ocrelizumab
Ommaya reservoir
opportunistic infection
opportunistic infection, CNS
papovavirus
pembrolizumab
phenylketonuria
plasmapheresis
plasmapheresis, complications of
pleocytosis of cerebrospinal fluid
polymerase chain reaction
polymerase chain reaction, false negative
polymyositis
polyneuropathy, chronic inflammatory demyelinating
posterior leukoencephalopathy syndrome
practice guidelines
preclinical
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
psoriasis
quality of life
radiation therapy, CNS treatment and complications with
remote effect of cancer on the nervous system
review article
rheumatoid arthritis
rheumatoid arthritis, neurologic complications of
risk factors
risk stratification
risk-benefit assessment
rituximab
safety
sarcoidosis
sarcoidosis, CNS
screening
serologic testing
seropositive
slow virus infection of CNS
steroid therapy, CNS treatment and complications with
symmetric brain lesions
systemic lupus erythematosus
treatment of neurologic disorder
tuberculosis
tumor necrosis factor inhibitor
upgaze
vaccination, neurologic complications with
vaccine
vasculitides
vasculopathy
vincristine neurotoxicity
viral infection
viral infection, CNS
weakness, progressive
Whipple's disease
white matter disease
workup
Showing articles 1150 to 1200 of 3169 << Previous Next >>

Clinicopath Conf., Eastern Equine Encephalitis
NEJM 359:294-303, Case 22-2008, 2008

Anti-Tumor Necrosis Factor Alpha-Associated Multiple Sclerosis
AJNR 26:1548-1550, Titelbaum,D.S.,et al., 2008

Steroid and Antiviral Treatment for Bells Palsy
Lancet 371:1818-1820, Hato,N.,et al, 2008

Tick-Borne Encephalitis
Lancet 371:1861-1871, Lindquist,L. &Vapalahti,O., 2008

Controlled Trial of High-Concentration Capsaicin Patch for Treatment of Painful HIV Neuropathy
Neurol 70:2305-2313, Simpson,D.M.,et al, 2008

Disease-Modifying Therapies for Alzheimers: New Drugs on the Horizon
Practical Neurology 7:16-23, Christensen,D.B., 2008

Anti-Ma and Anti-Ta Associated Paraneoplastic Neurological Syndromes: 22 Newly Diagnosed Patients and Review of Previous Cases
JNNP 79:767-773,742, Hoffmann,L.A.,et al, 2008

Phase 2 Safety Trial Targeting Amyloid � Production With a ?-Secretase Inhibitor in Alzheimer Disease
Arch Neurol 65:1031-1038, Fleisher,A.S.,et al., 2008

MR Imaging Findings in Hepatic Encephalopathy
AJNR 29:1612-1621, Rovira,A.,et al, 2008

Chikungunya Encephalomyeloradiculitis: Report of 2 Cases with Neuroimaging and 1 Case with autopsy Findings
AJNR 29:1636-1637, Ganesan,K.,et al, 2008

Efficacy and Safety of Oral Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase LLB Study
Lancet 372:1463-1472, Kappos,L.,et al, 2008

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008

Natalizumab Use in Pediatric Multiple Sclerosis
Arch Neurol 65:1655-1658, Huppke,P.,et al, 2008

Response of Anti-NMDA Receptor Encephalitis Without Tumor to Immunotherapy Including Rituximab
Neurol 71:1921-1923, Ishiura,H.,et al, 2008

Clinicopath Conf, Atypical Carcinoid Tumor with Limbic Encephalitis
NEJM 359:2155-2164, Case 35-2008, 2008

Treatment of Neuromyelitis Optica with Rituximab; Retrospective Analysis of 25 Patients
Arch Neurol 65:1443-1448, Jacob,A.,et al, 2008

Viral Meningitis
BMJ 336:36-40, Logan,S.A. &MacMahon,E., 2008

Human Immunodeficiency Virus Associated Intracranial Aneurysms: Report of Three Adult Patients With an Overview of the Literature
JNNP 79:44-46, Modi,G.,et al, 2008

NSAID Use and Dementia Risk in the Cardiovascular Health Study: Role of APOE and NSAID Type
Neurol 70:17-24, Szekely,C.A.,et al, 2008

Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stoke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)
Stroke 39:89-99, Adams,H.P.,Jr.,et al, 2008

Lymphomatoid Granulomatosis Involving Central Nervous System Successfully Treated With Rituximab alone
Arch Neurol 65:662-665, Ishiura,H.,et al, 2008

Neurologic Complications of Hepatitis C
The Neurologist 14:151-156, Acharya,J.N. &Pacheco,V.H., 2008

Primary Lateral Sclerosis With HIV-1 Infection
Neurol 70:575-577, Verma,A. &Berger,J.R., 2008

Anti-NMDA Receptor Encephalitis in Japan: Long-Term Outcome Without Tumor Removal
Neurol 70:504-511,500, Iizuka,T.,et al, 2008

B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008

Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008

Reversal of Transtentorial Herniation With Hypertonic Saline
Neurol 70:1023-1029,990, Koenig,M.A.,et al, 2008

Headache and Pregnancy
The Neurologist 14:108-119, Menon,R. &Bushnell,C.D., 2008

The Varicella Zoster Virus Vasculopathies: Clinical, CSF, Imaging, and Virologic Features
Neurol 70:853-860, Nagel,M.A.,et al, 2008

A Parkinsonian Syndrome in Methcathinone Users and the Role of Manganese
NEJM 358:1009-1017, Stepens,A.,et al, 2008

Changes in the Incidence and Predictors of Human Immunodeficiency Virus-Associated Dementia in the Era of Highly Active Antiretroviral Therapy
Ann Neurol 63:213-221, Bhaskaran,K.,et al, 2008

Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Hemorrhagic Stroke Risk: The Acute Brain Bleeding Analysis Study
Stroke 39:845-849, Choi,N.-K.,et al, 2008

Treatment-Responsive Subacute Limbic Encephalitis and NMDA Receptor Antibodies in a Man
Neurol 70:728-729, Novillo-Lopez,M.E.,et al, 2008

Recurrent Guillain-Barr� Syndrome
JNNP 80:56-59, Kuitwaard,K.,et al, 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Spectrum of Neurological Syndromes Associated with Glutamic Acid Decarboxylase Antibodes: Diagnostic Clues for this Association
Brain 131:2553-2563, Saiz,A., et al, 2008

Non-Paraneoplastic Limbic Encephalitis Associated with Anti-Glutamic Acid Decarboxylase Antibodies
J Neuroimmunol 199:155-159, Mata,S.,et al, 2008

Plasma Exchange for Anti GAD Associated Non Paraneoplastic Limbic Encephalitis
Transfus Apher Sci 39:229-233, Mazzi,G.,et al, 2008

Opsoclonus-Myoclonus-Ataxia Syndrome with Autoantibodies to Glutamic Acid Decarboxylase
Clin Neurol Neurosurg 110:619-621, Markakis,I.,et al, 2008

Nonvasculitic Autoimmune Inflammatory Meningoencephalitis as a Cause of Potentially Reversible Dementia
JNS 108:1024-1027, Lyons, M.,et al, 2008

A case of rheumatoid arthritis complicated by demyelination in both cerebral cortex and spinal cord during etanercept therapy
Mod Rheumatol 18:399-402, Kameda, T.,et al, 2008

Primary Central Nervous System Plasmablastic Lymphoma in AIDS
Neuropath Appl Neurobiol 34:245-247, Shuangshoti, S.,et al, 2008

Differential Diagnosis of Restricted Diffusion Confined to the Cerebral Cortex
Clin Radiol 63:1245-1253, Sheerin,F.,et al, 2008

Auto-Immune Cerebellar Ataxia with Anti-GAD Antibodies Accompanied by De Novo Late-Onset Type 1 Diabetes Mellitus
Diabetes Metab 34:386-388, Bayreuther,C.,et al, 2008

The Management of Encephalitis: Clinical Practice Guidelines by the Infectious Disease Society of America
Clinical Infectious Diseases 47:303-327, Tunkel, A.R.,et al, 2008

Central Nervous System Involvement after Herpes Zoster Ophthalmicus
Acta Ophthalmol 86:806-809, Haargaard, B.,et al, 2008

An Approach to the Diagnosis of Acute Transverse Myelitis
Semin Neurol 28:105-120, Jacob, A.,et al, 2008

Reversible Posterior Leukoencephalopathy Syndrome in 2 HIV-Infected Patients Receiving Antiretroviral Therapy
CID 49:e19-e22, Ridolfo, A.L.,et al, 2008

Severe Encephalomyelitis in an Immunocompetent Adult with Chromosomally Integrated Human Herpesvirus 6 and Clinical Response to Treatment with Foscarnet Plus Ganciclovir
Clin Infect Dis 47:e93-e94, Troy,S.B.,et al, 2008



Showing articles 1150 to 1200 of 3169 << Previous Next >>